MichaelStuartLeapmanMD

Surgical Oncology

Physician

Dr. Leapman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Minimally Invasive Urologic Surgery, 2014 - 2016
Icahn School of Medicine at Mount SinaiResidency, Urology, 2010 - 2014
Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 2009 - 2010
University of Maryland School of MedicineClass of 2009

PubMed

Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies.
Fuyao Chen, Roxana Esmaili, Ghazal Khajir, Tal Zeevi, Moritz Gross
European Urology Oncology. 2025-02-08
Prostate cancer in people with HIV.
Keith Sigel, Ryan Yu, Elizabeth Chiao, Ashish Deshmukh, Michael S Leapman
Current Opinion in Infectious Diseases. 2025-02-01
Urology on a changing planet: links between climate change and urological disease.
Alexander P Cole, Zhiyu Qian, Natasha Gupta, Michael Leapman, Hanna Zurl
Nature Reviews. Urology. 2025-01-28

Journal Articles

Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer
Michael Leapman, MD, JAMA Oncology

Lectures

Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.
2019 ASCO Annual Meeting - 6/1/2019

How to Avoid Overtreatment of Prostate CancerJanuary 15th, 2025
PSMA-PET Detects Hidden Metastasis in Recurrent Prostate CancerJanuary 8th, 2025
More Patients Opting for Close Monitoring of Early Stage Prostate CancerNovember 22nd, 2024
Join now to see all